Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Adverse Event
16%
Anxiety Disorder
16%
Beta1a Interferon
16%
Clinical Outcome
16%
Clinical Trial
66%
Comorbidity
100%
Confidence Interval
50%
Diabetes Mellitus
16%
Disease Activity
100%
Diseases
33%
Dyslipidemia
33%
Glatiramer
16%
Hazard Ratio
50%
Hypertension
16%
Medical History
16%
Migraine
33%
Multiple Sclerosis
100%
Nuclear Magnetic Resonance Imaging
33%
Prevalence
16%
Proportional Hazards Model
16%
Medicine and Dentistry
Adverse Event
16%
Anxiety Disorder
16%
Beta1a Interferon
16%
Clinical Trial
66%
Comorbidity
100%
Diabetes Mellitus
16%
Disease Activity
100%
Disease Modifying Therapy
16%
Diseases
16%
Dyslipidemia
33%
Glatiramer
16%
Hazard Ratio
50%
Hypertension
16%
Magnetic Resonance Imaging
33%
Medical History
16%
Migraine
33%
Multiple Sclerosis
100%
Prevalence
16%
Proportional Hazards Model
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
16%
Anxiety Disorder
16%
Beta1a Interferon
16%
Clinical Trial
66%
Comorbidity
100%
Diabetes Mellitus
16%
Disease Activity
100%
Diseases
33%
Dyslipidemia
33%
Glatiramer
16%
Hypertension
16%
Medical History
16%
Migraine
33%
Multiple Sclerosis
100%
Prevalence
16%
Neuroscience
Anxiety Disorder
16%
Comorbidity
100%
Diabetes Mellitus
16%
Dyslipidemia
33%
Glatiramer Acetate
16%
Hypertension
16%
Interferon Beta 1a
16%
Magnetic Resonance Imaging
33%
Migraine
33%
Multiple Sclerosis
100%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
66%
Comorbidity
100%
Dyslipidemia
33%
Interferon Beta 1a
16%
Magnetic Resonance Imaging
33%
Prevalence
16%
Keyphrases
Confirmed Disability Worsening
20%